All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease
{{output}}
Background & aims: Steatotic liver disease (SLD) is prevalent among patients with chronic hepatitis B (CHB). However, the effects of metabolic dysfunction-associated SLD (MASLD) on the long-term survival of such patients remain u... ...
